MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements, including revenue, expenses, profit, and loss

The total revenue of 6547 for the last quarter is 243.01 M TWD, and it's 38.68% higher compared to the previous quarter. The net income of Q3 24 is 1.51 M TWD.